Skip to main content

Possibilities and Limitations for Reversal of Age-Related Hair Loss

  • Chapter
  • First Online:
Aging Hair

Abstract

Our modern society faces an increasing life-expectation, and along with this, an increased desire for a youthful appearance. Hair plays a major role in our overall appearance, our self-conception and self-esteem. The experience of hair loss is distressing at any age and can reveal our aging process. Aging hair becomes more fragile, is thinner and sparser, and shows decreased growth rates. Age-related hair problems include senescent alopecia, androgenetic alopecia, graying, and weathering. Treatment option for androgenetic alopecia and senescent alopecia include, among others, topical minoxidil, oral finasteride, and hair restoration surgery. Hair loss can also be related to medication, underlying diseases, or surgery. Moreover, some inflammatory scalp diseases typically occur in older patients. This chapter discussed the management and treatment option of different forms of age-related hair loss.

Did equal amounts of work.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alajlan A, Shapiro J, Rivers JK et al (2005) Paradoxical hypertrichosis after laser epilation. J Am Acad Dermatol 53:85–88

    Article  PubMed  Google Scholar 

  2. Amory JK, Wang C, Swerdloff RS et al (2007) the effect of 5alpha reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endocrinol Metab 92:1659–1665

    Article  CAS  PubMed  Google Scholar 

  3. Anderson BE, Mackley CL, Helm KF (2003) Alopecia mucinosa: report of a case and review. J Cutan Med Surg 7: 124–128

    Article  PubMed  Google Scholar 

  4. Arca E, Kose O, Tastan HB et al (2004) Follicular mucinosis responding to isotretinoin treatment. J Dermatol Treat 15: 391–395

    Article  CAS  Google Scholar 

  5. Avram MR, Leonard RT, Epstein ES et al (2007) The current role of laser light sources in the treatment of male and female pattern hair loss. J Cosmet Laser Ther 9:27–28

    Article  Google Scholar 

  6. Barman JM, Astore I, Pecoraro V (1965) The normal trichogram of the adult. J Invest Dermatol 44:233–236

    CAS  PubMed  Google Scholar 

  7. Bianchi L, Paro Vidolin A, Piemonte P, Carboni I, Chimenti S (2001) Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A. Clin Exp Dermatol 26: 518–520

    Article  CAS  PubMed  Google Scholar 

  8. Birch MP, Messenger JF, Messenger AG (2001) Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 144:297–304

    Article  CAS  PubMed  Google Scholar 

  9. Bolduc C, Shapiro J (2000) Management of androgenetic alopecia. Am J Clin Dermatol 1:151–158

    Article  CAS  PubMed  Google Scholar 

  10. Bouzari N, Firooz AR (2006) Laser may induce terminal terminal hair growth. Dermatol Surg 32:460

    Article  CAS  PubMed  Google Scholar 

  11. Brenner S, Matz H (1999) Improvement in androgenetic alopecia in 53–76 year old men using oral finasteride. Int J Dermatol 38:928–930

    Article  CAS  PubMed  Google Scholar 

  12. Buhl AE, Waldon DJ, Baker CA et al (1990) Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol 95:553–557

    Article  CAS  PubMed  Google Scholar 

  13. Carey AH, Waterworth D, Patel K et al (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873–1876

    Article  CAS  PubMed  Google Scholar 

  14. Chieregato C, Zini A, Barba A et al (2003) Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol 74:784–786

    CAS  Google Scholar 

  15. Chumlea WC, Rhodes T, Girman CJ et al (2004) Family history and risk of hair loss. Dermatology 209:33–39

    Article  PubMed  Google Scholar 

  16. Clark RV, Hermann DJ, Cunningham GR et al (2004) Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5-alpha-reductase inhibitor. J Clin Endocrinol Metab 89:2179–2184

    Article  CAS  PubMed  Google Scholar 

  17. Courtois M, Loussouarn G, Hourseau C et al (1995) Ageing and hair cycles. Br J Dermatol 132:86–93

    Article  CAS  PubMed  Google Scholar 

  18. D’Amico AV, Roehrborn CG (2007) Effect 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenetic alopecia: a randomized controlled trial. Lancet Oncol 8:21–25

    Article  PubMed  Google Scholar 

  19. Dooley TP, Walker CJ, Hirshey SJ et al (1991) Localization of minoxidil sulfotransferase in rat liver and the outer root sheat of anagen pelage and vibrissa follicles. J Invest Dermatol 96:65–70

    Article  CAS  PubMed  Google Scholar 

  20. Draelos ZD (2006) Sunscreens and hair photoprotection. Dermatol Clin 24:81–84

    Article  CAS  PubMed  Google Scholar 

  21. Ellis JA, Stebbing M, Harrap SB (1998) Genetic analysis of male pattern baldness and the 5alpha-reductase genes. J Invest Dermatol 110:849–853

    Article  CAS  PubMed  Google Scholar 

  22. Ellis JA, Sinclair R, Harrap SB (2004) Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 4:1–11

    Google Scholar 

  23. Emmerson RW (1969) Follicular mucinosis. A study of 47 patients. Br J Dermatol 81:395

    Article  CAS  PubMed  Google Scholar 

  24. Friedman ES, Friedman PM, Cohen DE et al (2002) Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol 46:309–312

    Article  PubMed  Google Scholar 

  25. Galbrait GM, Thiers BH (1985) In vitro suppression of human lymphocyte by minoxidil. Int J Dermatol 24: 249–251

    Article  Google Scholar 

  26. Gibson LE, Muller SA, Peters MS (1988) Follicular ­mucinosis of childhood and adolescence. Pediatr Dermatol 5: 231–235

    Article  CAS  PubMed  Google Scholar 

  27. Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann NY Acad Sci 53:708–728

    Article  CAS  PubMed  Google Scholar 

  28. Han JH, Kwon OS, Chung JH et al (2004) Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle. J Dermatol Sci 34:91–98

    Article  CAS  PubMed  Google Scholar 

  29. Harrison S, Sinclair R (2002) Telogen effluvium. Clin Exp Dermatol 27:389–385

    Article  CAS  PubMed  Google Scholar 

  30. Harthi FA, Kudwah A, Ajlan A et al (2003) Urticaria-like follicular mucinosis responding to dapsone. Acta Derm Venereol 83:389–390

    Article  PubMed  Google Scholar 

  31. Headington JT (1996) Cicatricial alopecia. Dermatol Clin 14:773–782

    Article  CAS  PubMed  Google Scholar 

  32. Headington JT, Novak E (1984) Clinical and histologic studies of male pattern hair baldness treated with topical minoxidil. Curr Ther Res 36:1098–1106

    Google Scholar 

  33. Hibberts NA, Howell AE, Randall VA (1998) Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 156:59–65

    Article  CAS  PubMed  Google Scholar 

  34. Hillmer AM, Brockschmidt FF, Hanneken S et al (2008) Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 40:1279–1281

    Article  CAS  PubMed  Google Scholar 

  35. Hoffman RM (1998) Topical liposome targeting of dyes, melanins, genes and proteins electively to hair follicle. J Drug Target 5:67–74

    Article  CAS  PubMed  Google Scholar 

  36. Hordinsky M, Sawaya M, Roberts JL (2002) Hair loss and hirsutism in the elderly. Clin Geriatr Med 18:121–133

    Article  PubMed  Google Scholar 

  37. Hordinsky MK, Wietgrefe MM, Sevenich E et al (1985) Immune function in alopecia areata patients applying 3% topical minoxidil. Clin Res 33:646A

    Google Scholar 

  38. Imperato-McGinley J (2002) 5alpha-reductase-2 deficiency and complete androgen insensitivity: lessons from nature. Adv Exp Med Biol 511:121–131

    CAS  PubMed  Google Scholar 

  39. Iorizzo M, Vincenzi C, Voudouris S et al (2006) Finasteride treatment of female pattern hair loss. Arch Dermatol 142: 298–302

    Article  CAS  PubMed  Google Scholar 

  40. Kaufman KD, Olsen EA, Whiting D et al (1998) Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 39:578–589

    Article  CAS  PubMed  Google Scholar 

  41. Kligman AM (1959) The human hair cycle. J Invest Dermatol 33:307–316

    CAS  PubMed  Google Scholar 

  42. Kligman AM (1988) The comparative histopathology of male-pattern baldness and senescent baldness. Clin Dermatol 6:108–118

    Article  CAS  PubMed  Google Scholar 

  43. Kodama H, Umemura S, Nohara N (1988) Follicular mucinosis: response to indomethacin. J Dermatol 15:72–75

    CAS  PubMed  Google Scholar 

  44. Lachgar S, Charveron M, Gall Y et al (1998) Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol 138: 407–411

    Article  CAS  PubMed  Google Scholar 

  45. Leyden J, Dunlap F, Miller B et al (1999) Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 40:930–937

    Article  CAS  PubMed  Google Scholar 

  46. Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247

    Article  CAS  PubMed  Google Scholar 

  47. Meisheri KD, Cipkus LA, Taylor CJ (1988) Mechanism of action of minoxidil sulfate-induced vasodilation: a role for increased K+ permeability. J Pharmacol Exp Ther 245: 751–760

    CAS  PubMed  Google Scholar 

  48. Morton CC, Byers MG, Nakai H, Bell GI, Shows TB. Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22 – q24.1, 11p15 and 4q25 – q27, respectively. Cytogenet Cell Genet 1986:41(4):245–249

    Article  CAS  PubMed  Google Scholar 

  49. Mondaini N, Gontero P, Giubilei G et al (2007) Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med 4:1708–1712

    Article  PubMed  Google Scholar 

  50. Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J 68:1359–1365

    CAS  PubMed  Google Scholar 

  51. Olsen E (1989) Treatment of androgenetic alopecia with topical minoxidil. Res Staff Phys 53:35

    Google Scholar 

  52. Olsen E, Stenn K, Bergfeld W et al (2003) Update on cicatricial alopecia. J Investig Dermatol Symp Proc 8:18–19

    Article  CAS  PubMed  Google Scholar 

  53. Olsen EA (1999) The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women. J Am Acad Dermatol 40:106–109

    Article  CAS  PubMed  Google Scholar 

  54. Olsen EA, Bergfeld WF, Cotsarelis G et al (2003) Summary of North American Hair Research Society (NAHRS)-sponsored workshop on Cicatricial Alopecia, Duke University Medical Center, 10 and 11 February 2001. J Am Acad Dermatol 48:103–110

    Article  PubMed  Google Scholar 

  55. Olsen EA, Hordinsky M, Whiting D et al (2006) The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol 55:1014–1023

    Article  PubMed  Google Scholar 

  56. Olszewska M, Rudnicka L (2005) Effective treatment of female androgenetic alopecia with dutasteride. J Drugs Dermatol 4:637–640

    PubMed  Google Scholar 

  57. Otberg N, Finner AM, Shapiro J (2007) Androgenetic alopecia. Endocrinol Metab Clin North Am 36:379–398

    Article  CAS  PubMed  Google Scholar 

  58. Otberg N, Wu WY, McElwee KJ et al (2008) Diagnosis and management of primary cicatricial alopecia: part I. Skinmed 7:19–26

    Article  PubMed  Google Scholar 

  59. Overstreet JW, Fug VL, Gould J et al (1999) Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol 162:1295–1300

    Article  CAS  PubMed  Google Scholar 

  60. Passaro EM, Silveira MT, Valente NY (2004) Acneiform follicular mucinosis. Clin Exp Dermatol 29:396–398

    Article  CAS  PubMed  Google Scholar 

  61. Peluso AM, Misciali C, Vincenzi C et al (1997) Diffuse hypertrichosis during treatment with 5% topical minoxidil. Br J Dermatol 136:118–120

    Article  CAS  PubMed  Google Scholar 

  62. Price VH (1999) Treatment of hair loss. N Engl J Med 341:964–973

    Article  CAS  PubMed  Google Scholar 

  63. Price VH, Roberts JL, Hordinski M et al (2000) Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 43:768–776

    Article  CAS  PubMed  Google Scholar 

  64. Randall VA, Ebling FJ (1991) Seasonal changes in human hair growth. Br J Dermatol 124:146–151

    Article  CAS  PubMed  Google Scholar 

  65. Rhodes L, Harper J, Gaito H et al (1994) The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone in adult male and female stump-tail macaques (Macaca arctoides). J Clin Endocrinol Metab 29: 291–296

    Google Scholar 

  66. Richards JB, Yuan X, Geller F et al (2008) Male-pattern baldness susceptibility locus at 20p11. Nat Genet 40: 1282–1284

    Article  CAS  PubMed  Google Scholar 

  67. Roberts JL, Fiedler V, Imperato-McGinley J et al (1999) Clinical dose ranging studies with finasteride, a type 2 5-alpha reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol 41:555–563

    CAS  PubMed  Google Scholar 

  68. Roehrborn CG, Boyle P, Nickel JC et al (2002) Efficacy and safety of dual inhibitor of 5alpha reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 60:434–441

    Article  PubMed  Google Scholar 

  69. Rundegren J (2004) Pattern alopecia: what clinical features determine the response to topical minoxidil treatment? JDDG 2:500

    Google Scholar 

  70. Rushton DH, Ramsay ID, Norris MJ et al (1991) Natural progression of male pattern baldness in young men. Clin Exp Dermatol 16:188–192

    Article  CAS  PubMed  Google Scholar 

  71. Safavi KH, Muller SA, Suman VJ et al (1995) Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 70:628–633

    Article  CAS  PubMed  Google Scholar 

  72. Sellheyer K, Bergfeld WF (2006) Histopathologic evaluation of alopecias. Am J Dermatopathol 28:236–259

    Article  PubMed  Google Scholar 

  73. Shapiro J (2007) Clinical practice. Hair loss in women. N Engl J Med 18:1620–1630

    Article  Google Scholar 

  74. Shapiro J, Price VH (1998) Hair regrowth therapeutic agents. Dermatol Clin 16:341–356

    Article  CAS  PubMed  Google Scholar 

  75. Sinclair R, Grossman KL, Kvedar JC (2003) Anagen hair loss. McGraw-Hill, New York

    Google Scholar 

  76. Sperling LC, Lupton GP (1995) Histopathology of non-scarring alopecia. J Cutan Pathol:97–114

    Article  CAS  PubMed  Google Scholar 

  77. Sperling LC, Solomon AR, Whiting DA (2000) A new look at scarring alopecia. Arch Dermatol 136:235–242

    Article  CAS  PubMed  Google Scholar 

  78. Tajima M, Hamada C, Arai T et al (2007) Characteristic features of Japanese women’s hair with aging and with progressing hair loss. J Dermatol Sci 45:93–103

    Article  PubMed  Google Scholar 

  79. Thompson MI, Goodman PJ, Tangen CM et al (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215–224

    Article  CAS  PubMed  Google Scholar 

  80. Tolgyesi E (1983) Weathering of hair. Cosmet Toilet 98: 29–33

    Google Scholar 

  81. Tosti A, Iorizzo M, Piraccini BM (2005) Androgenetic alopecia in children: report of 20 cases. Br J Dermatol 152: 556–559

    Article  CAS  PubMed  Google Scholar 

  82. Trueeb RM (2004) Finasteride treatment of patterned hair loss in normoandrogenetic postmenopausal women. Dermatology 209:202–207

    Article  CAS  Google Scholar 

  83. Trueeb RM (2005) Aging of hair. J Cosm Derm 4:60–72

    Article  Google Scholar 

  84. Unger WP, Unger RH (2003) Hair transplanting: An important but often forgotten treatment for female pattern hair loss. J Am Acad Dermatol 49:853–860

    Article  PubMed  Google Scholar 

  85. Uno H (1986) The stump-tailed macaque as a model for baldness: effects of minoxidil. Int J Cosmet Sci 8:63–71

    Article  CAS  PubMed  Google Scholar 

  86. van Doorn R, Scheffer E, Willemze R (2002) Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. Arch Dermatol 138: 191–198

    Article  PubMed  Google Scholar 

  87. von Kobyletzki G, Kreuter JA, Nordmeier R et al (2000) Treatment of idiopathic mucinosis follicularis with UVA1 cold light phototherapy. Dermatology 201:76–77

    Article  Google Scholar 

  88. Weiss VC, West DP (1985) Topical minoxidil therapy and hair regrowth. Arch Dermatol 121:191–192

    Article  CAS  PubMed  Google Scholar 

  89. Wester RC, Maibach HI, Guy RH et al (1984) Minoxidil stimulates cutaneous blood flow in human balding scalp: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol 82: 515–517

    Article  CAS  PubMed  Google Scholar 

  90. Whiting DA (1996) Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 35:899–906

    Article  CAS  PubMed  Google Scholar 

  91. Whiting DA (2001) Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies Eur J Dermatol 11:332–334

    CAS  PubMed  Google Scholar 

  92. Whiting DA (2003) Histopathologic features of alopecia areata: a new look. Arch Dermatol 139:1555–1559

    Article  PubMed  Google Scholar 

  93. Whiting DA, Waldstreicher J, Sanchez M et al (1999) Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: result of finasteride 1 mg treatment of men and postmenopausal women. J Invest Dermatol Symp Proc 4:282–284

    Article  CAS  Google Scholar 

  94. Whiting DA, Olsen EA, Savin R et al (2003) Efficacy and tolerability of finasteride 1 mg in men aged 41–60 years with male pattern hair loss. Eur J Dermatol 13:150–160

    CAS  PubMed  Google Scholar 

  95. Wu WY, Otberg N, McElwee KJ et al (2008) Diagnosis and management of primary cicatricial alopecia: part II. Skinmed 7:78–83

    Article  PubMed  Google Scholar 

  96. York J, Nicholson T, Minors P et al (1998) Stressful life events and loss of hair among adult women, a case-control study. Psychol Rep 82:1044–1046

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nina Otberg .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Otberg, N., Restrepo, I., Shapiro, J. (2010). Possibilities and Limitations for Reversal of Age-Related Hair Loss. In: Trüeb, R., Tobin, D. (eds) Aging Hair. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02636-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-02636-2_18

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-02635-5

  • Online ISBN: 978-3-642-02636-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics